“Matinas BioPharma (MTNB)… Turning now to the rest of the Street, other analysts echo Hazlett’s sentiment. As only Buy recommendations have been published in the last three months, MTNB earns a Strong Buy analyst consensus. With the average price target… Continue Reading…